GSK fund manager activity
GSK plc · NYSE. Reported by 10 tracked fund managers in their 13F filings, Q2 2022 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Sarah Ketterer - Causeway Capital Management | Trimmed | 33,897 | $1,662,321 | 0.02% | Feb 13, 2026 |
| Dodge & Cox Funds | Trimmed | 68,517,969 | $3,360,121,200 | 1.81% | Feb 13, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 33,195,985 | $1,627,931,136 | 0.56% | Feb 9, 2026 |
| Jeremy Grantham - GMO | Added | 3,489,374 | $171,118,901 | 0.44% | Feb 17, 2026 |
| Hillman Capital Management | Trimmed | 114,336 | $5,607,037 | 3.53% | Feb 17, 2026 |
| Kahn Brothers Group | Trimmed | 178,696 | $8,763,251 | 1.55% | Feb 12, 2026 |
| Richard Pzena - Pzena Investment Management | Added | 13,444 | $659,292 | 0.00% | Feb 6, 2026 |
| Tweedy Browne | No change | 82,243 | $4,033,197 | 0.33% | Feb 3, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Sarah Ketterer - Causeway Capital Management | Added | 1,177,001 | $50,799,344 | 0.67% | Nov 13, 2025 |
| Dodge & Cox Funds | Trimmed | 78,403,734 | $3,383,905,159 | 1.83% | Nov 13, 2025 |
| Ken Fisher - Fisher Asset Management | Added | 32,227,615 | $1,390,943,886 | 0.50% | Nov 12, 2025 |
| Jeremy Grantham - GMO | Trimmed | 2,572,126 | $111,012,958 | 0.31% | Nov 13, 2025 |
| Hillman Capital Management | Trimmed | 141,779 | $6,119,182 | 3.56% | Nov 14, 2025 |
| Kahn Brothers Group | Trimmed | 260,837 | $11,257,724 | 2.12% | Nov 12, 2025 |
| Richard Pzena - Pzena Investment Management | Added | 8,717 | $376,237 | 0.00% | Nov 7, 2025 |
| Tweedy Browne | Trimmed | 82,243 | $3,549,608 | 0.31% | Nov 20, 2025 |
Newer quarters · Older quarters